Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03646227 · ClinicalTrials.gov registry record
Multi-Drug Resistant Organism Network
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 6,496
- Enrollment target
NCT03646227: Completed study, sponsored by Duke University.
NCT03646227 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 6,496 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03646227 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 6,496 participants
- Enrollment target
Study Summary
This study is specifically designed to provide observational data which can be used to help in the design of future randomized clinical trials on both therapeutics and diagnostics for MDRO infections. To this end, clinical and epidemiological data will be collected on patients who have MDRO isolated from clinical cultures during hospitalization, as well as descriptions of the outcomes of patients treated with various antimicrobial regimens. Molecular and microbiological characterization will also be performed on MDRO isolates. These data will include a detailed clinical and epidemiological description of patients including identifying potential barriers to enrollment in future trials. In addition, data will be collected on species, strain type, and mechanism of drug resistance of the causative organism. Knowing the molecular characteristics will further inform future trial design as not all diagnostics detect and not all therapeutics are active against the same mechanisms of resistance.
Primary Outcome
The disposition at discharge is a composite of different locations, to which the subject is discharged (skilled nursing facility, home, long term acute care facility, transfer to another hospital, death, or hospice) and it is used to compare patient outcomes based on MDRO collected form the subject.
Interventions
- OTHER Standard of Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,496 participants |
| Start Date | 2016-06-16 |
| Est. Completion | 2020-05-30 |
What the finished NCT03646227 record still lists
NCT03646227 is an observational study that tracks outcomes without assigning an intervention. Its 6,496 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Standard of Care is the first listed.
NCT03646227 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03646227 about?
NCT03646227 is a clinical study titled "Multi-Drug Resistant Organism Network". This study is specifically designed to provide observational data which can be used to help in the design of future randomized clinical trials on both therapeutics and diagnostics for MDRO infections. To this end, clinical and epidemiological data will be collected on patients who have MDRO isolated...
What is the current status of trial NCT03646227?
This trial is currently completed. The enrollment target is 6,496 participants. The study started on 2016-06-16. Estimated completion is 2020-05-30.
What interventions are being tested in trial NCT03646227?
The interventions under investigation include: Standard of Care (OTHER).
Who is sponsoring clinical trial NCT03646227?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00505245 · 6,500 participants
New Assessment System in Measuring Symptom Distress in Cancer Patients
- NCT06821009 · 6,500 participants · NA
Effectiveness of a Cloud-based Digital Health Navigation Program for Colorectal Cancer Screening
- NCT05369429 · 6,516 participants · NA
My Wellbeing Guide: a Novel Tool for Managing Stress and Improving Quality of Life
- NCT05143697 · 6,600 participants · NA
Motivational Wellness Coaching to Reduce Childhood Obesity in Families and Kids
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI